Search Results

SimBioSys announced today it has entered a strategic collaboration with UT Southwestern to support the expansion of its PhenoScope platform, the company’s proprietary multi-modal data analysis platform which generates novel insights for discovery and clinical development, including unique spatial biophysical insights in 4-dimension space.

RenovoRx, Inc today announced that the University of Texas (UT) Southwestern Medical Center is now enrolling pancreatic cancer patients in the open label, randomized Phase III TIGeR-PaC clinical trial.

BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, announced that it has entered into a clinical trial agreement with the Mays Cancer Center at The University of Texas Health Science Center at San Antonio and Swedish Orphan Biovitrum AB, a specialized international biopharmaceutical company.

Watertown Regional Medical Center and Healthcare Outcomes Performance Company have joined forces to provide top-tier orthopedic and spine care for patients.

Actinium Pharmaceuticals, Inc. announced it will host a KOL call on Monday, May 20, 2024, at 8:00 AM ET to provide updates and highlight its recently announced clinical trial to study Iomab-ACT with a leading FDA approved CAR-T cell therapy at the University of Texas Southwestern.

Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announces the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center utilizing the advanced Genesis Robotic Magnetic Navigation System.

OncoNano Medicine, Inc. today announced a multi-year collaboration with The University of Texas Southwestern Medical Center (UTSW) to discover and conduct translational research of novel cancer therapeutics that leverage OncoNano’s core nanotechnology platform.

Dallas-based UT Southwestern Medical Center’s Simmons Cancer Center, one of the elite centers in the country for patient care, research and education joins Caris’ best-in-class collaborative research network focused on expanding the application of precision medicine in oncology

Ractigen Therapeutics announces a formal collaboration with University Medical Center Utrecht, affiliated with Utrecht University.